A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy have?
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy has 207 citations in the OpenAlex counts ScholarIQ stores.
When was A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy published?
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy has 2023 year in the ScholarIQ index.
What is the open-access status of A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy?
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy has green oa status in the ScholarIQ index.
What is the DOI of A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy?
The DOI for A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy is on the source record.
What is the PMID of A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy?
The PMID for A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy is on the source record.
What is the OpenAlex record for A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy?
The OpenAlex for A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy is on the source record.